Announcement • Jul 07
Craftport Cannabis Corp. Announces Appointment of Wenjie Zhang as Member of Board of Directors Craftport Cannabis Corp. announced that effective June 12, 2023, Ms. Wenjie Zhang has been reappointed as a member of the Company's Board of Directors in order to enhance the ability for the Company to meet Health Canada's requirements. Reported Earnings • Nov 25
Third quarter 2022 earnings released: CA$0.013 loss per share (vs CA$0.036 loss in 3Q 2021) Third quarter 2022 results: CA$0.013 loss per share. Net loss: CA$738.9k (flat on 3Q 2021). Announcement • Oct 04
Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022 Craftport Cannabis Corp., Annual General Meeting, Dec 09, 2022. Reported Earnings • Aug 30
Second quarter 2022 earnings released: CA$0.029 loss per share (vs CA$0.13 loss in 2Q 2021) Second quarter 2022 results: CA$0.029 loss per share (up from CA$0.13 loss in 2Q 2021). Net loss: CA$841.1k (loss narrowed 69% from 2Q 2021). Announcement • Jul 20
Craftport Cannabis Corp. announced that it has received CAD 3 million in funding On July 19, 2022, Craftport Cannabis Corp. closed the transaction. On the same day, the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its final tranche. The common shares of the company issued pursuant to the offering are subject to resale restrictions for a period of four months and a day expiring on November 19, 2022. Announcement • May 28
Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in funding Craftport Cannabis Corp. announce a non-brokered private placement offering 37,500,000 common shares at a price of CAD 0.08 per common share for gross proceeds of CAD 3,000,000 on May 27, 2022. The company expects to close the transaction on or about June 30, 2022.
On the same date the company issued 18,750,000 common shares for gross proceeds of CAD 1,500,000 in its first tranche. the common shares issued pursuant to the first tranche are subject to resale restrictions for a period of four months and a day expiring on September 28, 2022. No finders fees have been or will be paid in connection with the offering. Reported Earnings • May 05
Full year 2021 earnings released: CA$0.49 loss per share (vs CA$0.55 loss in FY 2020) Full year 2021 results: CA$0.49 loss per share (up from CA$0.55 loss in FY 2020). Revenue: CA$1.01m (up 18% from FY 2020). Net loss: CA$10.1m (flat on FY 2020). Announcement • Apr 09
Craftport Cannabis Corp. Announces Board Changes Craftport Cannabis Corp. announced that effective April 6, 2022, Wenjie Zhang resigned as a member of the Company's Board of Directors in order to allow her to focus on her other professional duties. The Company also announced that, effective April 6, 2022, Yuan Gao was appointed to the Company's Board of Directors. Gao has been employed by the Company since March 2021, and as such, has a deep understanding of the Company's operations. Announcement • Jan 26
Craftport Cannabis Corp. announced that it expects to receive CAD 3 million in funding Craftport Cannabis Corp. announce a non-brokered private placement offering of up to 15,000,000 common shares at a price of CAD 0.20 per common share for gross proceeds of CAD 3,000,000 on January 25, 2022. The offering price of CAD 0.20 represents a 25% premium to the company's last closing price on the Canadian Securities Exchange on January 24, 2022 of CAD 0.16 per common share. The common shares issued pursuant to the offering will be subject to resale restrictions for a period of four months and a day from the date of issuance. The closing of the transaction is subject to certain customary conditions, including Canadian Securities Exchange approval. No finders’ fees will be paid in connection with the transaction. The company expects to close the offering by March 8, 2022. Reported Earnings • Nov 29
Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations Third quarter 2021 results: CA$0.036 loss per share (down from CA$0.001 profit in 3Q 2020). Revenue: CA$317.9k (up 2.5% from 3Q 2020). Net loss: CA$734.2k (down CA$755.6k from profit in 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings. Board Change • Nov 24
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Chairman George Dorin was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • May 31
First quarter 2021 earnings released: CA$0.004 loss per share (vs CA$0.005 loss in 1Q 2020) First quarter 2021 results: Net loss: CA$739.8k (loss narrowed 15% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 62% per year, which means it is performing significantly worse than earnings. Announcement • Mar 20
Benchmark Botanics Inc. Announces Board Changes Benchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO. Announcement • Mar 19
Benchmark Botanics Inc. Announces Executive Changes Benchmark Botanics Inc. announced that the company has determined that a new CEO would be beneficial in leading Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Benchmark to the next stage of its growth. To that end, effective immediately, Mr. William Ying has resigned as the Company's Chief Executive Officer and board of director. Mr. Terry Wang has been appointed as the Company's Interim Chief Executive Officer as the Board engages in a process to identify a permanent CEO. Announcement • Nov 18
Benchmark Botanics, Inc. Announces Appointment of Mike Cosic to Board of Directors Benchmark Botanics Inc. announced the appointment of Mr. Mike Cosic to the Company's board of directors. Mr. Cosic is currently the CFO of Meta Growth Corp. He was previously the CFO at both DLT Labs Inc. and Lithium Americas Corp., and currently sits on the Board of Directors and is Audit Committee Chairman of Eastern Platinum Limited. Announcement • Nov 17
Benchmark Botanics Inc. Announces Resignation of James Moore as Director Benchmark Botanics Inc. announces that Mr. James Moore has resigned from its Board of Directors. The Board has accepted Mr. Moore's resignation and wishes to thank Mr. Moore for his service and dedication to the Company. Announcement • Nov 06
Benchmark Botanics Inc. Announces CFO Changes Benchmark Botanics Inc. appointed David Li, MBA, CPA-IL, as its new Chief Financial Officer. Mr. Li will be replacing Paul Haber in this role. David Li comes to Benchmark with a wealth of public company expertise having helped many companies successfully navigate the capital markets. Announcement • Sep 02
Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders. Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for CAD 5.4 million on July 7, 2020. The consideration includes issuance of 30 million shares by Benchmark in exchange for 5.2 million Common shares of 1139000. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. Closing of the transactions is subject to compliance with the requirements of the Canadian Securities Exchange and applicable securities laws. The transaction is expected to close on August 15, 2020.
Benchmark Botanics Inc. (CNSX:BBT) completed the acquisition of additional 25.9% stake in 1139000 B.C. Ltd. from shareholders on August 31, 2020. All consideration shares issued are subject to a statutory hold period expiring four months and one day after the closing of the transaction. Announcement • Aug 12
Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million. Benchmark Botanics Inc. (CNSX:BBT) entered into a share exchange agreement to acquire additional 25.9% stake in 1139000 B.C. Ltd. from shareholders for $5.4 million on August 11, 2020. Benchmark currently owns 5 million Common shares of 1139000 and after completion of the transactions contemplated under the Agreement, Benchmark will own 10,199,000 Common shares, which will represent 51% of issued and outstanding share capital of 1139000. The consideration includes issuance of 26.9 million shares by Benchmark in exchange for their 5.2 million Common shares of 1139000. The transaction is expected to close on August 15, 2020. 